-
Loading metrics
Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments
- S. De Groot,
- H. M. Blommestein,
- W. K. Redekop,
- S. Sleijfer,
- L. A. L. M. Kiemeney,
- E. Oosterwijk,
- C. A. Uyl-de Groot
x
- Published: May 22, 2017
- https://doi.org/10.1371/journal.pone.0177364